Fangzhou and Tencent Healthcare Launch AI-Powered Chronic Disease Management Solution to Transform Healthcare

Published: 28 Nov 2025

Author: Precedence Research

Share :

The collaboration between Fangzhou Inc. and Tencent Healthcare has led to the launch of a breakthrough initiative, AI+Chronic Disease Management. This marks the first significant move toward integrating artificial intelligence into the Chinese healthcare industry. The unique partnership offers healthcare professionals an integrated, end-to-end technology pipeline, including AI model training and deployment to improve the productivity and scale of chronic disease management. The solution is based on the AI + H2H (Hospital-to-Home) ecosystem of Fangzhou. The proprietary large-model AI capabilities can be easily integrated into existing chronic disease management workflows, enabling hospitals, clinics, and home care to offer an incredibly personalized patient management system.

Tencent Healthcare brings its strong cloud capabilities and AI to the alliance, offering a technological foundation that enables fast data processing and real-time semantic retrieval. The hybrid platform enables continuous model optimization, making AI suggestions reliable and clinically sound. This collaborative solution aims to enhance patient outcomes and streamline clinical processes. Further, decreasing the workload of health care professionals and strengthening the sense of connection, intelligence, and responsiveness across the entire chronic care ecosystem in China.

The AI+Chronic Disease Management solution allows clinicians to provide highly personalized care through analyzing large volumes of patient data. This allows for identifying possible complications at an early stage, creating customized treatment plans that increase patient adherence and outcomes. Furthermore, it stated that the AI+Chronic Disease Management solution transforms the global chronic care environment by enhancing efficiency, clinical outcomes, and patient experience.

Executive Statement

Dr. Xie Fangmin, Founder, Chairman, and CEO of Fangzhou

“By combining Fangzhou’s specialized healthcare and chronic disease management expertise with Tencent Healthcare’s industrial-grade infrastructure, we are bringing validated, scalable AI capabilities to the entire healthcare ecosystem and setting a new standard for the evolution of chronic-disease management in China. This collaboration allows us to deliver intelligent, high-efficiency solutions that benefit both patients and healthcare providers, and it represents a significant milestone in our mission to make healthcare more accessible and effective.”